BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Slavicek J, Puretić Z, Novak M, Sarnavka V, Benjak V, Glavas-Boras S, Thune S. The role of plasma exchange in the treatment of severe forms of hemolytic-uremic syndrome in childhood. Artif Organs 1995;19:506-10. [PMID: 8526789 DOI: 10.1111/j.1525-1594.1995.tb02370.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Arnold DM, Patriquin CJ, Nazy I. Thrombotic microangiopathies: a general approach to diagnosis and management. CMAJ 2017;189:E153-9. [PMID: 27754896 DOI: 10.1503/cmaj.160142] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 4.7] [Reference Citation Analysis]
2 Winters JL, Pineda AA, Mcleod BC, Grima KM. Therapeutic apheresis in renal and metabolic diseases. J Clin Apheresis 2000;15:53-73. [DOI: 10.1002/(sici)1098-1101(2000)15:1/2<53::aid-jca5>3.0.co;2-w] [Cited by in Crossref: 40] [Article Influence: 1.8] [Reference Citation Analysis]
3 Esplin MS, Branch DW. Diagnosis and Management of Thrombotic Microangiopathies During Pregnancy: . Clinical Obstetrics and Gynecology 1999;42:360-7. [DOI: 10.1097/00003081-199906000-00020] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
4 Scheiring J, Andreoli SP, Zimmerhackl LB. Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). Pediatr Nephrol 2008;23:1749-60. [PMID: 18704506 DOI: 10.1007/s00467-008-0935-6] [Cited by in Crossref: 183] [Cited by in F6Publishing: 140] [Article Influence: 13.1] [Reference Citation Analysis]
5 Amouroux C, Adra AL, Mouba JF, Tenenbaum J, Ichay L, Dalla-Vale F, Milesi C, Morin D. [Hemolytic uremic syndrome with severe neurological involvement: how should it be managed?]. Arch Pediatr 2012;19:150-5. [PMID: 22245485 DOI: 10.1016/j.arcped.2011.11.015] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Goldwater PN, Bettelheim KA. Treatment of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic uremic syndrome (HUS). BMC Med 2012;10:12. [PMID: 22300510 DOI: 10.1186/1741-7015-10-12] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 5.9] [Reference Citation Analysis]
7 Zhao SA, Ning BT, Mao JH. Clinical characteristics of children with hemolytic uremic syndrome in Hangzhou, China. World J Pediatr 2017;13:183-5. [PMID: 28353273 DOI: 10.1007/s12519-017-0021-x] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Giordano P, Netti GS, Santangelo L, Castellano G, Carbone V, Torres DD, Martino M, Sesta M, Di Cuonzo F, Resta MC, Gaeta A, Milella L, Chironna M, Germinario C, Scavia G, Gesualdo L, Giordano M. A pediatric neurologic assessment score may drive the eculizumab-based treatment of Escherichia coli-related hemolytic uremic syndrome with neurological involvement. Pediatr Nephrol 2019;34:517-27. [PMID: 30362078 DOI: 10.1007/s00467-018-4112-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
9 Scheiring J, Rosales A, Zimmerhackl LB. Clinical practice. Today's understanding of the haemolytic uraemic syndrome. Eur J Pediatr 2010;169:7-13. [PMID: 19707787 DOI: 10.1007/s00431-009-1039-4] [Cited by in Crossref: 86] [Cited by in F6Publishing: 63] [Article Influence: 6.6] [Reference Citation Analysis]